CHVKF(CHVKF)
CHVKF
No analyst ratings available
No analyst price targets available for CHVKF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $176.56B | $143.77B | $136.92B |
| Low | $141.18B | $96.02B | $101.16B |
| High | $212.01B | $209.60B | $180.65B |
| EBITDA Avg | $56M | $46M | $43M |
| Low | $45M | $30M | $32M |
| High | $67M | $66M | $57M |
| EBIT Avg | $-62.87B | $-51.19B | $-48.75B |
| Low | $-75.49B | $-74.63B | $-64.32B |
| High | $-50.27B | $-34.19B | $-36.02B |
| Net Income Avg | $-27.29B | $-19.39B | $-11.35B |
| Low | $-38.62B | $-27.44B | $-16.06B |
| High | $-18.02B | $-12.81B | $-7.50B |
| EPS Avg | $-2.30 | $-1.63 | $-0.95 |
| Low | $-3.25 | $-2.31 | $-1.35 |
| High | $-1.52 | $-1.08 | $-0.63 |
| Analysts (Rev / EPS) | 8 / 1 | 7 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $24.75B | $87.49B | $19.23B | $48.64B | $18.99B | $56.96B |
| Low | $24.75B | $87.49B | $19.23B | $48.64B | $18.99B | $56.96B |
| High | $24.75B | $87.49B | $19.23B | $48.64B | $18.99B | $56.96B |
| EBITDA Avg | $8M | $28M | $6M | $15M | $6M | $18M |
| Low | $8M | $28M | $6M | $15M | $6M | $18M |
| High | $8M | $28M | $6M | $15M | $6M | $18M |
| EBIT Avg | $-8.81B | $-31.15B | $-6.85B | $-17.32B | $-6.76B | $-20.28B |
| Low | $-8.81B | $-31.15B | $-6.85B | $-17.32B | $-6.76B | $-20.28B |
| High | $-8.81B | $-31.15B | $-6.85B | $-17.32B | $-6.76B | $-20.28B |
| Net Income Avg | $-2.13B | $-4.02B | $-1.65B | $-12.08B | $-4.72B | $-14.15B |
| Low | $-2.13B | $-4.02B | $-1.65B | $-12.08B | $-4.72B | $-14.15B |
| High | $-2.13B | $-4.02B | $-1.65B | $-12.08B | $-4.72B | $-14.15B |
| EPS Avg | $-0.18 | $-0.34 | $-0.14 | $-1.02 | $-0.40 | $-1.19 |
| Low | $-0.18 | $-0.34 | $-0.14 | $-1.02 | $-0.40 | $-1.19 |
| High | $-0.18 | $-0.34 | $-0.14 | $-1.02 | $-0.40 | $-1.19 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |